IFN-β1b (recombinant human)   Click here for help

GtoPdb Ligand ID: 8340

Synonyms: Betaferon® | Betaseron® | Extavia® | IFNb1b
Approved drug Immunopharmacology Ligand
IFN-β1b (recombinant human) is an approved drug (FDA (1993), EMA (1995))
Compound class: Peptide or derivative
Comment: Compared to the sequence of endogenous IFN-β, IFN-β1b has a Ser to Cys substitution at position 17, but does not retain the glycosylation site at Asn80. It also lacks the initiating Met. This recombinant peptide is produced in E.coli.
Classification Click here for help
Compound class Peptide or derivative
Approved drug? Yes (FDA (1993), EMA (1995))
International Nonproprietary Names Click here for help
INN number INN
5380 interferon beta
Synonyms Click here for help
Betaferon® | Betaseron® | Extavia® | IFNb1b
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 641
Other databases
DrugBank Ligand DB00068
GtoPdb PubChem SID 252166552
Search PubMed clinical trials interferon beta
Search PubMed titles interferon beta
Search PubMed titles/abstracts interferon beta
Wikipedia Interferon_beta_1b